MLAB

Mesa Laboratories, Inc. [MLAB] Stock Forecast

Q: What is Mesa Laboratories, Inc. stock symbol ?

Mesa Laboratories, Inc. is a US stock, located in Lakewood of Co and trading under the symbol MLAB

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

MLAB Stock Summary

Earnings have grown 18.85% per last year.

EPS has increased from the previous quarter and is now positive. (Quarter statements)

Earnings are expected to fall -100% next year

EPS has been decreasing for the past 3 years (Yearly statements)

MLAB has less than 1 year of cash runway

Top 10 Correlated ETFs

MLAB

Top 10 Correlated Stocks

MLAB

In the News

MLAB Financial details

Company Rating

Buy

Market Cap

566.43M

Income

948K

Revenue

212.87M

Book val./share

74.72

Cash/share

5.23

Dividend

0.64

Dividend %

0.63%

Employees

698

Optionable

Shortable

Yes

Earnings

24 May 2024

P/E

-766.5

Forward P/E

PEG

145.23

P/S

2.57

P/B

1.42

P/C

19.05

P/FCF

15.12

Quick Ratio

1.81

Current Ratio

2.96

Debt / Equity

0.59

LT Debt / Equity

0.58

EPS (TTM)

0.17

EPS next Y

EPS next Q

EPS this Y

-52.78%

EPS next Y

EPS next 5Y

EPS last 5Y

-38.61%

Revenue last 5Y

16.26%

Revenue Q/Q

0.58%

EPS Q/Q

-269.57%

SMA20

SMA50

9.57%

SMA100

14.44%

Inst Own

77.19%

Inst Trans

0.84%

ROA

ROE

ROC

-0.01%

Gross Margin

60%

Oper. Margin

-3%

Profit Margin

Payout

-479%

Shs Outstand

Shs Float

Target Price

52W Range

82.86-178.64

52W High

-44.03%

52W Low

+21.49%

RSI

Rel Volume

0.65

Avg Volume

46.51K

Volume

30.24K

Perf Week

-4.26%

Perf Month

-12.69%

Perf Quarter

3.16%

Perf Half Y

-6.79%

Beta

0.825

Volatility

2.19%, 3.54%

Prev Close

Price

99.62

Change

-1.38%

MLAB Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-03-31

Metric	2019-03-31	2020-03-31	2021-03-31	2022-03-31	2023-03-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	26.87	28.02	26.92	35.37	41.17
Net income per share	1.95	0.32	0.66	0.36	0.17
Operating cash flow per share	7.96	6.32	7.45	7.53	5.26
Free cash flow per share	7.63	5.97	7.05	6.68	4.4
Cash per share	2.65	19.38	53.04	9.47	6.18
Book value per share	28.99	52.38	81.65	75.56	73.95
Tangible book value per share	3.05	-9.86	26.86	-28.3	16.69
Share holders equity per share	28.99	52.38	81.65	75.56	73.95
Interest debt per share	5.92	34.97	31.1	43.17	33.24
Market cap	878.71M	949.58M	1.21B	1.33B	929.74M
Enterprise value	891.26M	1.01B	1.09B	1.5B	1.07B
P/E ratio	117.41	703.91	370.01	710.01	999.72
Price to sales ratio	8.52	8.07	9.04	7.21	4.24
POCF ratio	28.76	35.75	32.68	33.87	33.23
PFCF ratio	30	37.89	34.53	38.18	39.67
P/B Ratio	7.89	4.32	2.98	3.37	2.36
PTB ratio	7.89	4.32	2.98	3.37	2.36
EV to sales	8.64	8.58	8.17	8.14	4.87
Enterprise value over EBITDA	25.21	124.79	88.55	319.06	321.42
EV to operating cash flow	29.17	38.01	29.52	38.25	38.13
EV to free cash flow	30.43	40.28	31.19	43.12	45.53
Earnings yield	0.01	0	0	0	0
Free cash flow yield	0.03	0.03	0.03	0.03	0.03
Debt to equity	0.2	0.64	0.36	0.56	0.44
Debt to assets	0.15	0.34	0.24	0.31	0.26
Net debt to EBITDA	0.36	7.42	-9.48	36.53	41.37
Current ratio	1.42	4.72	9.3	2.59	2.74
Interest coverage	0	-0.89	-0.66	-5.24	-8.22
Income quality	4.08	19.69	11.32	20.96	30.09
Dividend Yield	0	0	0	0	0
Payout ratio	0.33	2.02	0.97	1.78	3.66
Sales general and administrative to revenue	0.3	0.32	0.34	0.33	0.33
Research and developement to revenue	0.03	0.05	0.08	0.09	0.09
Intangibles to total assets	0.64	0.62	0.45	0.77	0.46
Capex to operating cash flow	-0.04	-0.06	-0.05	-0.11	-0.16
Capex to revenue	-0.01	-0.01	-0.01	-0.02	-0.02
Capex to depreciation	-0.13	-0.12	-0.11	-0.18	-0.13
Stock based compensation to revenue	0.04	0.05	0.07	0.06	0.06
Graham number	35.66	19.46	34.77	24.7	17.05
ROIC	0.06	-0.01	-0.01	-0.02	0.13
Return on tangible assets	0.13	0.01	0.01	0.01	0
Graham Net	-5.86	-22.82	18.77	-42.4	-34.99
Working capital	9.96M	96.78M	270.43M	76.26M	75.62M
Tangible asset value	11.72M	-41.39M	133.65M	-147.48M	88.81M
Net current asset value	-11.83M	-77.4M	109.09M	-189.25M	-149.38M
Invested capital	0.2	0.64	0.36	0.56	0.44
Average receivables	13.41M	16.82M	22.46M	32.51M	41.89M
Average payables	2.64M	3.15M	3.94M	6.19M	7.02M
Average inventory	8M	10.5M	12.7M	17.89M	29.62M
Days sales outstanding	44.29	65.54	64.82	81.63	70.89
Days payables outstanding	25.05	23.58	34.79	38.31	26.22
Days of inventory on hand	58.55	98.46	86.95	119.36	148.08
Receivables turnover	8.24	5.57	5.63	4.47	5.15
Payables turnover	14.57	15.48	10.49	9.53	13.92
Inventory turnover	6.23	3.71	4.2	3.06	2.46
ROE	0.07	0.01	0.01	0	0
Capex per share	-0.33	-0.36	-0.4	-0.85	-0.85

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q3

Metric	2022-12-31	2023-03-31	2023-06-30	2023-09-30	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	10.17	10.39	9.43	9.87	9.92
Net income per share	0.08	0.11	-0.1	-0.23	0.39
Operating cash flow per share	1.45	2.34	1.85	1.81	2.14
Free cash flow per share	1.14	2.15	1.8	1.7	1.93
Cash per share	5.21	6.15	6.28	6.9	5.23
Book value per share	72.52	73.56	72.17	71.98	74.72
Tangible book value per share	-22.86	-20.52	-18.88	-17.3	-32.63
Share holders equity per share	72.52	73.56	72.17	71.98	74.72
Interest debt per share	35.63	34.95	33.39	32.38	44.12
Market cap	887.4M	934.63M	690.3M	566.01M	565.02M
Enterprise value	1.05B	1.09B	836.23M	703.91M	772.9M
P/E ratio	491.9	382.42	-314.35	-115.04	66.76
Price to sales ratio	16.35	16.81	13.63	10.65	10.57
POCF ratio	114.98	74.66	69.45	57.9	48.98
PFCF ratio	146.34	81.32	71.39	61.91	54.29
P/B Ratio	2.29	2.38	1.78	1.46	1.4
PTB ratio	2.29	2.38	1.78	1.46	1.4
EV to sales	19.35	19.57	16.51	13.24	14.45
Enterprise value over EBITDA	90.1	2.1K	101.42	91.7	60.14
EV to operating cash flow	136.09	86.9	84.14	72	67
EV to free cash flow	173.21	94.65	86.49	77	74.27
Earnings yield	0	0	0	0	0
Free cash flow yield	0.01	0.01	0.01	0.02	0.02
Debt to equity	0.49	0.47	0.46	0.45	0.59
Debt to assets	0.29	0.28	0.28	0.27	0.32
Net debt to EBITDA	13.98	296.38	17.7	17.97	16.18
Current ratio	2.74	2.74	2.93	2.96	2.68
Interest coverage	2.93	-10.75	-0.63	-0.07	-0.04
Income quality	17.11	20.49	-18.1	-7.95	5.45
Dividend Yield	0	0	0	0	0
Payout ratio	1.9	1.4	-1.56	-0.7	0.41
Sales general and administrative to revenue	0.3	0.32	0.36	0.33	0.36
Research and developement to revenue	0.09	0.09	0.09	0.09	0.08
Intangibles to total assets	0.77	0.76	0.76	0.75	0.78
Capex to operating cash flow	-0.21	-0.08	-0.03	-0.06	-0.1
Capex to revenue	-0.03	-0.02	-0.01	-0.01	-0.02
Capex to depreciation	-0.19	-0.11	-0.03	-0.08	-0.12
Stock based compensation to revenue	0.04	0.05	0.06	0.06	0.06
Graham number	11.74	13.75	12.88	19.23	25.68
ROIC	0	0.03	0	0	0
Return on tangible assets	0	0	0	-0.01	0.01
Graham Net	-37.33	-34.81	-32.88	-31.29	-49.25
Working capital	72.57M	75.62M	75.68M	77.85M	74.17M
Tangible asset value	-122.05M	-109.78M	-101.43M	-93.19M	-176M
Net current asset value	-161.59M	-149.38M	-140.08M	-131.77M	-220.45M
Invested capital	0.49	0.47	0.46	0.45	0.59
Average receivables	42.1M	42.47M	39.07M	35.97M	36.18M
Average payables	7.01M	6.21M	5.86M	5.2M	4.68M
Average inventory	30.89M	34.19M	35.1M	34.22M	34.43M
Days sales outstanding	70.28	68.89	63.26	61.52	60.63
Days payables outstanding	26.29	24.66	25.84	20.56	20.42
Days of inventory on hand	141.09	139.25	164.44	140.54	161.31
Receivables turnover	1.28	1.31	1.42	1.46	1.48
Payables turnover	3.42	3.65	3.48	4.38	4.41
Inventory turnover	0.64	0.65	0.55	0.64	0.56
ROE	0	0	0	0	0.01
Capex per share	-0.31	-0.19	-0.05	-0.12	-0.21

MLAB Dividend History

MLAB Frequently Asked Questions

What is Mesa Laboratories, Inc. stock symbol ?

Mesa Laboratories, Inc. is a US stock , located in Lakewood of Co and trading under the symbol MLAB

What is Mesa Laboratories, Inc. stock quote today ?

Mesa Laboratories, Inc. stock price is $99.62 today.

Is Mesa Laboratories, Inc. stock public?

Yes, Mesa Laboratories, Inc. is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 46.51K
Market Capitalization 566.43M
Employee 698
CEO Mr. Gary M. Owens
Headquarters Lakewood,CO,US
IPO Date 1984-02-29
Website https://www.mesalabs.com

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.